Literature DB >> 24310212

Screening of natural compounds as activators of the keap1-nrf2 pathway.

Kai C Wu1, Peter R McDonald2, Jie Liu3, Curtis D Klaassen3.   

Abstract

Nuclear factor erythroid 2-related factor 2 is a master regulator that promotes transcription of cytoprotective genes in response to oxidative/electrophilic stress. A large number of natural dietary compounds are thought to protect against oxidative stress, and a few have been reported to induce genes involved in antioxidant defense through activating nuclear factor erythroid 2-related factor 2. Therefore, a library of 54 natural compounds were collected to determine whether they are nuclear factor erythroid 2-related factor 2 activators and to compare their efficacy and potency to activate nuclear factor erythroid 2-related factor 2. The assay utilized AREc32 cells that contain a luciferase gene under the control of antioxidant response element promoters. Each natural compound was tested at 13 concentrations between 0.02 and 30 µM. Known nuclear factor erythroid 2-related factor 2 activators tert-butylhydroquinone and 2-cyano-3,12-dioxooleana-1,9-diene-28-imidazolide were used as positive controls in parallel with the natural compounds. Among the 54 tested natural compounds, andrographolide had the highest efficacy, followed by trans-chalcone, sulforaphane, curcumin, flavone, kahweol, and carnosol, all of which had better efficacy than tert-butylhydroquinone. Among the compounds tested, 2-cyano-3,12-dioxooleana-1,9-diene-28-imidazolide was the most potent, having an EC50 of 0.41 µM. Seven of the natural compounds, namely andrographolide, trans-chalcone, sulforaphane, curcumin, flavone, kahweol, and cafestol had lower EC50 values than tert-butylhydroquinone but higher than 2-cyano-3,12-dioxooleana-1,9-diene-28-imidazolide. The present study provides insights into which natural compounds activate the Keap1-nuclear factor erythroid 2-related factor 2 pathway and thus might be useful for detoxifying oxidative/electrophilic stress. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24310212      PMCID: PMC5505507          DOI: 10.1055/s-0033-1351097

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  42 in total

1.  Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.

Authors:  Donna D Zhang; Shih-Ching Lo; Zheng Sun; Geetha M Habib; Michael W Lieberman; Mark Hannink
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

2.  Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals.

Authors:  Andreas Natsch; Roger Emter
Journal:  Toxicol Sci       Date:  2007-10-11       Impact factor: 4.849

Review 3.  Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.

Authors:  Young-Joon Surh; Joydeb Kumar Kundu; Hye-Kyung Na
Journal:  Planta Med       Date:  2008-10-20       Impact factor: 3.352

4.  Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.

Authors:  Pei-Yi Tsai; Shuk-Man Ka; Jia-Ming Chang; Hsiang-Cheng Chen; Hao-Ai Shui; Chen-Yun Li; Kuo-Feng Hua; Wen-Liang Chang; Jiann-Jyh Huang; Sung-Sen Yang; Ann Chen
Journal:  Free Radic Biol Med       Date:  2011-05-23       Impact factor: 7.376

5.  Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo.

Authors:  Andy Y Shih; Sophie Imbeault; Vilte Barakauskas; Heidi Erb; Lei Jiang; Ping Li; Timothy H Murphy
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

6.  Sites of alkylation of human Keap1 by natural chemoprevention agents.

Authors:  Yan Luo; Aimee L Eggler; Dongting Liu; Guowen Liu; Andrew D Mesecar; Richard B van Breemen
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-02       Impact factor: 3.109

7.  Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.

Authors:  Larry G Higgins; Christophe Cavin; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-26       Impact factor: 4.219

8.  Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway.

Authors:  Alexander Hess; Nastiti Wijayanti; Andrea Pathe Neuschäfer-Rube; Norbert Katz; Thomas Kietzmann; Stephan Immenschuh
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

9.  Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.

Authors:  Shunsuke Tanigawa; Makoto Fujii; De-Xing Hou
Journal:  Free Radic Biol Med       Date:  2007-02-28       Impact factor: 7.376

10.  Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.

Authors:  Kai Connie Wu; Julia Yue Cui; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

View more
  29 in total

Review 1.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

Review 2.  Unfolding Nrf2 in diabetes mellitus.

Authors:  Tapan Behl; Ishnoor Kaur; Aayush Sehgal; Eshita Sharma; Arun Kumar; Madhuri Grover; Simona Bungau
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

3.  Resveratrol prevents protein nitration and release of endonucleases from mitochondria during acetaminophen hepatotoxicity.

Authors:  Kuo Du; Mitchell R McGill; Yuchao Xie; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Food Chem Toxicol       Date:  2015-04-09       Impact factor: 6.023

4.  Identification of potential andrographolide-based drug candidate against Keap1-Nrf2 pathway through rigorous cheminformatics screening.

Authors:  Priyanka Jain; C Sudandira Doss
Journal:  Mol Divers       Date:  2022-04-25       Impact factor: 2.943

5.  Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.

Authors:  Tatsuro Iso; Takafumi Suzuki; Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

6.  Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis.

Authors:  Samantha Cialfi; Rocco Palermo; Sonia Manca; Carlo De Blasio; Paula Vargas Romero; Saula Checquolo; Diana Bellavia; Daniela Uccelletti; Michele Saliola; Angelo D'Alessandro; Lello Zolla; Alberto Gulino; Isabella Screpanti; Claudio Talora
Journal:  Cell Cycle       Date:  2014-05-06       Impact factor: 4.534

Review 7.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 8.  Discovery and development of natural product oridonin-inspired anticancer agents.

Authors:  Ye Ding; Chunyong Ding; Na Ye; Zhiqing Liu; Eric A Wold; Haiying Chen; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

9.  Mitochondrial Protection Promoted by the Coffee Diterpene Kahweol in Methylglyoxal-Treated Human Neuroblastoma SH-SY5Y Cells.

Authors:  Marcos Roberto de Oliveira; Izabel Cristina Custódio de Souza; Cristina Ribas Fürstenau
Journal:  Neurotox Res       Date:  2019-09-07       Impact factor: 3.911

Review 10.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.